strain_accession,species_name,species_id,gene_name,card_accession,mechanism,AMR_gene_ref_strain,card_drug_class,definition,amr_seqid,contig,strand,position,coverage,identity,host,source,source_detail,country,date,MLST,subspecies_id,subspecies_name
DRR161218,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,DRR161218_AMRSEG0001,NODE_11_length_203441_cov_20.657593,negative,86220-86551,96.23,87.05,,,,,,,,
DRR161218,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,DRR161218_AMRSEG0002,NODE_4_length_275462_cov_20.618056,negative,147359-148045,100.0,86.75,,,,,,,,
DRR161218,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",DRR161218_AMRSEG0003,NODE_7_length_232053_cov_21.202685,positive,134001-137480,99.08,81.0,,,,,,,,
GCF_001556905.1,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001556905.1_AMRSEG0001,NZ_LSKA01000021.1,positive,1507-2193,100.0,87.05,Environment,Environment: patient environment,Environment:Patient environment:hospital shower hose biofilm,United States of America,2016/2/10,159.0,,
GCF_001556905.1,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001556905.1_AMRSEG0002,NZ_LSKA01000197.1,positive,35452-35783,96.23,86.45,Environment,Environment: patient environment,Environment:Patient environment:hospital shower hose biofilm,United States of America,2016/2/10,159.0,,
GCF_001556905.1,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001556905.1_AMRSEG0003,NZ_LSKA01000256.1,positive,6748-10217,98.71,81.05,Environment,Environment: patient environment,Environment:Patient environment:hospital shower hose biofilm,United States of America,2016/2/10,159.0,,
GCF_001557045.1,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,GCF_001557045.1_AMRSEG0001,NZ_LSKL01000155.1,negative,78688-79374,100.0,87.05,Environment,Environment: patient environment,Environment:Patient environment:hospital shower hose biofilm,United States of America,2016/2/10,159.0,,
GCF_001557045.1,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,GCF_001557045.1_AMRSEG0002,NZ_LSKL01000240.1,positive,42395-42726,96.23,86.45,Environment,Environment: patient environment,Environment:Patient environment:hospital shower hose biofilm,United States of America,2016/2/10,159.0,,
GCF_001557045.1,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",GCF_001557045.1_AMRSEG0003,NZ_LSKL01000442.1,negative,54542-58011,98.71,81.05,Environment,Environment: patient environment,Environment:Patient environment:hospital shower hose biofilm,United States of America,2016/2/10,159.0,,
SRR13785998,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR13785998_AMRSEG0001,NODE_10_length_121336_cov_41.276995,negative,91964-95433,98.71,80.94,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,2011/3/26,,,
SRR13785998,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR13785998_AMRSEG0002,NODE_11_length_120102_cov_39.498321,negative,8043-8374,96.23,86.45,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,2011/3/26,,,
SRR13785998,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR13785998_AMRSEG0003,NODE_29_length_73656_cov_39.920550,positive,4186-4872,100.0,87.05,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,2011/3/26,,,
SRR13785999,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR13785999_AMRSEG0001,NODE_12_length_121336_cov_45.881359,positive,25904-29373,98.71,80.94,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,2011/3/26,,,
SRR13785999,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR13785999_AMRSEG0002,NODE_27_length_73656_cov_44.381042,positive,4186-4872,100.0,87.05,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,2011/3/26,,,
SRR13785999,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR13785999_AMRSEG0003,NODE_4_length_184560_cov_45.144718,positive,175874-176205,96.23,86.45,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,2011/3/26,,,
SRR13786000,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR13786000_AMRSEG0001,NODE_12_length_121336_cov_43.743249,negative,91964-95433,98.71,80.94,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,2011/3/26,,,
SRR13786000,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR13786000_AMRSEG0002,NODE_26_length_73656_cov_42.588453,negative,68785-69471,100.0,87.05,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,2011/3/26,,,
SRR13786000,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR13786000_AMRSEG0003,NODE_5_length_184247_cov_41.821814,positive,175874-176205,96.23,86.45,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,2011/3/26,,,
SRR13786053,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR13786053_AMRSEG0001,NODE_13_length_106052_cov_36.334997,positive,3890-4576,100.0,86.17,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,2011/4/15,,,
SRR13786053,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR13786053_AMRSEG0002,NODE_2_length_195324_cov_34.915354,negative,85399-85730,96.23,87.05,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,2011/4/15,,,
SRR13786053,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR13786053_AMRSEG0003,NODE_4_length_164771_cov_37.193081,negative,140443-143912,98.71,81.05,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,2011/4/15,,,
SRR13786057,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR13786057_AMRSEG0001,NODE_1_length_150419_cov_31.967843,positive,64691-65022,96.23,87.05,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,,,
SRR13786057,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR13786057_AMRSEG0002,NODE_44_length_45984_cov_37.157706,positive,41450-42136,100.0,86.17,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,,,
SRR13786057,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR13786057_AMRSEG0003,NODE_66_length_33348_cov_34.733904,negative,23568-27037,98.71,81.05,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,,,
SRR13827026,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR13827026_AMRSEG0001,NODE_10_length_121000_cov_48.406435,positive,25904-29373,98.71,80.94,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,,,
SRR13827026,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR13827026_AMRSEG0002,NODE_11_length_119784_cov_47.184437,negative,7725-8056,96.23,86.45,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,,,
SRR13827026,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR13827026_AMRSEG0003,NODE_29_length_72315_cov_47.629311,positive,2845-3531,100.0,87.05,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,,,
SRR13827027,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR13827027_AMRSEG0001,NODE_2_length_234843_cov_54.598339,positive,132689-133375,100.0,86.17,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,,,
SRR13827027,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR13827027_AMRSEG0002,NODE_4_length_195347_cov_51.971524,positive,109618-109949,96.23,87.05,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,,,
SRR13827027,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR13827027_AMRSEG0003,NODE_7_length_164771_cov_53.077191,negative,140443-143912,98.71,81.05,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,,,
SRR13827028,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR13827028_AMRSEG0001,NODE_14_length_118280_cov_37.449267,negative,53689-57158,98.8,81.04,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,204.0,,
SRR13827028,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR13827028_AMRSEG0002,NODE_33_length_75076_cov_36.504086,positive,2852-3538,100.0,87.05,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,204.0,,
SRR13827028,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR13827028_AMRSEG0003,NODE_5_length_174247_cov_35.162805,negative,85367-85698,96.23,86.45,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,204.0,,
SRR13827029,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR13827029_AMRSEG0001,NODE_11_length_118280_cov_40.873597,positive,61123-64592,98.8,81.04,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,204.0,,
SRR13827029,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR13827029_AMRSEG0002,NODE_32_length_75076_cov_39.883287,negative,71539-72225,100.0,87.05,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,204.0,,
SRR13827029,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR13827029_AMRSEG0003,NODE_4_length_174247_cov_38.961001,positive,88550-88881,96.23,86.45,Homo sapiens,Homo sapiens,Homo sapiens_no_further_detail,United States of America,,204.0,,
SRR15973855,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR15973855_AMRSEG0001,NODE_23_length_81175_cov_57.237166,positive,59375-59706,96.23,86.75,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extraplumonary:blood,Israel,2019/3/1,,,
SRR15973855,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR15973855_AMRSEG0002,NODE_24_length_78193_cov_55.032536,negative,4306-7775,98.68,81.26,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extraplumonary:blood,Israel,2019/3/1,,,
SRR15973855,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR15973855_AMRSEG0003,NODE_70_length_29725_cov_56.264345,negative,26757-27443,100.0,87.05,Homo sapiens,Homo sapiens: extrapulmonary,Homo sapiens:extraplumonary:blood,Israel,2019/3/1,,,
SRR6046323,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR6046323_AMRSEG0001,NODE_15_length_96445_cov_32.578064,positive,66326-69795,98.71,80.91,Homo sapiens,Homo sapiens,Homo sapiens:clinical sample,United Kingdom,2016/3/31,,,
SRR6046323,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR6046323_AMRSEG0002,NODE_17_length_92480_cov_30.500298,negative,88967-89653,100.0,87.05,Homo sapiens,Homo sapiens,Homo sapiens:clinical sample,United Kingdom,2016/3/31,,,
SRR6046323,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR6046323_AMRSEG0003,NODE_5_length_157029_cov_30.434585,positive,44053-44384,96.23,86.45,Homo sapiens,Homo sapiens,Homo sapiens:clinical sample,United Kingdom,2016/3/31,,,
SRR8483013,phocaicum,319706,RbpA,ARO:3000245,antibiotic target protection,Mycolicibacterium smegmatis MC2 155,rifamycin antibiotic,RNA-polymerase binding protein which confers resistance to rifampin.,SRR8483013_AMRSEG0001,NODE_11_length_170925_cov_142.943440,negative,147670-148001,96.23,86.45,,,,Portugal,2017/9/1,844.0,,
SRR8483013,phocaicum,319706,mtrA,ARO:3000816,antibiotic efflux,Mycobacterium tuberculosis H37Rv,penam;macrolide antibiotic,MtrA is a transcriptional activator of the MtrCDE multidrug efflux pump of Neisseria gonorrhoeae.,SRR8483013_AMRSEG0002,NODE_12_length_157025_cov_134.025751,positive,4050-4736,100.0,87.05,,,,Portugal,2017/9/1,844.0,,
SRR8483013,phocaicum,319706,rpoB2,ARO:3000501,antibiotic target alteration,Nocardia farcinica IFM 10152,rifamycin antibiotic,"Due to gene duplication, the genomes of Nocardia species include both rifampin-sensitive beta-subunit of RNA polymerase (rpoB) and rifampin-resistant beta-subunit of RNA polymerase (rpoB2) genes, with ~88% similarity between the two gene products. Expression of the rpoB2 variant results in replacement of rifampin sensitivity with rifampin resistance.",SRR8483013_AMRSEG0003,NODE_1_length_410364_cov_142.053293,positive,271529-274998,98.71,80.82,,,,Portugal,2017/9/1,844.0,,